Company / Inventory
ResMed Inventory History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$927.7M
FY2025
5-year range
$457.0M / $998.0M
FY2021-FY2025
Trend
+12.8%
vs FY2024
Sector context
#26 of 118
Health Care
What the data says
ResMed's inventory of $928M is higher than 78% of companies in the Health Care sector (FY2025). Declined from $998M to $928M over the past 2 years.
Based on SEC 10-K filings.
$928M in FY2025 with a 5-year CAGR of +17.3%. Top quartile in the Health Care sector.
Declined from $998M to $928M over the past 2 years.
Health Care sector context is included.
Inventory over time
Growth rates
- 3-Year CAGR
- +7.6%
- 5-Year CAGR
- +17.3%
- 10-Year CAGR
- -
Sector benchmark
Top 22% in Health CareTop 22% of 118This company $927.7M Sector average $1.4B
▼
-34.8% below sector average
Key checks
Key Insights
- 5-year CAGR of +17.3%, indicating consistent growth.
- In FY2025, inventory increased 12.8% year-over-year.
- Ranks #26 out of 118 companies in the Health Care sector.
- Peak inventory was recorded in FY2023.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 3.25 (safe zone, above 2.9 threshold)
- Strong profit margin: 27.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $927.7M | +12.8% |
| FY2024 | $822.3M | -17.6% |
| FY2023 | $998.0M | +34.2% |
| FY2022 | $743.9M | +62.8% |
| FY2021 | $457.0M | +9.6% |
| FY2020 | $416.9M | +19.2% |
| FY2019 | $349.6M | +30.1% |
| FY2018 | $268.7M | +0.1% |
| FY2017 | $268.3M | +19.5% |
| FY2016 | $224.5M | -9.1% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026